Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Differentiated Thyroid Carcinoma (DTC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05007093
What this trial is testing

Study on the Treatment of Differentiated Thyroid Carcinoma with Anlotinib

Who this might be right for
DTC - Differentiated Thyroid Cancer
Yansong Lin 20
Not applicableLooking for participantsNCT06855680
What this trial is testing

The EMIRATES Study

Who this might be right for
Differentiated Thyroid Cancer (DTC)
Royal Marsden NHS Foundation Trust 15
Not applicableUnknownNCT05510934
What this trial is testing

Shared Care Thyroid Cancer Follow-up Utilizing Thyroid Cancer Assessment Reminder System (TCARS) Study - A Pilot Study.

Who this might be right for
Low Risk Differentiated Thyroid Cancer
Nova Scotia Health Authority 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07453225
What this trial is testing

Empirical Radioactive Iodine Therapy in DTC

Who this might be right for
Differentiated Thyroid Cancer
Assiut University 100
Testing effectiveness (Phase 2)Study completedNCT04447183
What this trial is testing

RhTSH for Radioactive Iodine Remnant Ablation in Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 123
Testing effectiveness (Phase 2)Looking for participantsNCT07092514
What this trial is testing

Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC)

Who this might be right for
Thyroid CancerCancer of the Thyroid
Washington University School of Medicine 34
Not applicableLooking for participantsNCT06405217
What this trial is testing

Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment

Who this might be right for
DTC - Differentiated Thyroid CancerThyroid Stimulating; Hormone, CRadiotherapy; Complications
Nanjing First Hospital, Nanjing Medical University 30
Testing effectiveness (Phase 2)UnknownNCT04952493
What this trial is testing

Anlotinib or Penpulimab in Combination With RAI for DTC

Who this might be right for
Thyroid Cancer
Peking Union Medical College Hospital 42
Large-scale testing (Phase 3)Study completedNCT01321554
What this trial is testing

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC)

Who this might be right for
Thyroid Cancer
Eisai Inc. 392
Testing effectiveness (Phase 2)Study completedNCT02432274
What this trial is testing

Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma

Who this might be right for
TumorsSolid Malignant TumorsOsteosarcoma+1 more
Eisai Limited 117
Not applicableLooking for participantsNCT06980103
What this trial is testing

Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer

Who this might be right for
Thyroid Cancer
Georgetown University 408
Not applicableNot Yet RecruitingNCT07536412
What this trial is testing

Decision Aid Efficacy in Low Risk Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer (DTC)Papillary Thyroid MicrocarcinomaPapillary Thyroid Carcinoma
University of Maryland, Baltimore 34
Large-scale testing (Phase 3)Enrolling By InvitationNCT07620574
What this trial is testing

Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study

Who this might be right for
CancerRenal Cell Carcinoma (RCC)Pancreatic Neuroendocrine Tumors (pNET)+6 more
Exelixis 5,000
Testing effectiveness (Phase 2)Study completedNCT01788982
What this trial is testing

Nintedanib(BIBF1120) in Thyroid Cancer

Who this might be right for
Medullary Thyroid Cancer (MTC)Differentiated Thyroid Cancer (DTC)
European Organisation for Research and Treatment of Cancer - EORTC 100
Large-scale testing (Phase 3)Study completedNCT02966093
What this trial is testing

A Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China

Who this might be right for
Differentiated Thyroid Cancer (DTC)
Eisai Co., Ltd. 151
Post-approval studies (Phase 4)Ended earlyNCT03065218
What this trial is testing

99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients

Who this might be right for
Thyroid Cancer
Medstar Health Research Institute 4
Testing effectiveness (Phase 2)Ended earlyNCT03630120
What this trial is testing

Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer

Who this might be right for
Thyroid CancerThyroid Cancer, MedullaryDifferentiated Thyroid Cancer+3 more
H. Lee Moffitt Cancer Center and Research Institute 6
Early research (Phase 1)Looking for participantsNCT07287748
What this trial is testing

A Phase I Trial of Af-001 in Patients With Differentiated Thyroid Cancer

Who this might be right for
DTC - Differentiated Thyroid Cancer
Alpha Fusion Inc. 38
Large-scale testing (Phase 3)Active Not RecruitingNCT04940052
What this trial is testing

Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer (DTC)
Novartis Pharmaceuticals 153